Stock Scorer

Balance Labs, Inc. (BLNC)

Balance Labs, Inc. reported revenue of 7.3K USD for the quarter ending 30 June 2026, down 89.1% from 67.5K a year earlier.

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than filled in. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. The same series drawn ›

As last reported

The newest period the filing supports for each figure, in USD.
FigurePeriodAmountYear on year
Revenue Q2 '26 · ending 30 June 2026 7.3K -89.1%
Gross Profit Q2 '15 · ending 30 June 2015 -10.5K —
Operating Income Q2 '26 · ending 30 June 2026 -500.6K —
Net Income Q2 '26 · ending 30 June 2026 -236.8K —
Cost of Revenue Q2 '15 · ending 30 June 2015 30K —
Operating Cash Flow Q2 '26 · ending 30 June 2026 -98.9K —
Free Cash Flow Q4 '21 · ending 31 December 2021 5K —
Shares Outstanding Q2 '26 · ending 30 June 2026 46.9M +80.5%
EPS Q2 '26 · ending 30 June 2026 -1.23 —

Revenue and profit by financial year

As filed, in USD. A year the filing does not support is not listed.
YearEnding RevenueOperating IncomeNet IncomeFree Cash Flow
20252025-12-31 6K-13.1M-31.8M—
20222022-12-31 247.5K-22.8K-768.4K—
20212021-12-31 624.6K224.4K-796.7K-66.4K
20202020-12-31 1M612.5K357.8K—
20192019-12-31 3.3K-557.9K-884.2K—
20182018-12-31 6.7K-603.1K-547.7K-424.4K
20172017-12-31 500-533.6K-837.2K—

Every period

Revenue Quarterly

PeriodEndingRevenue
Q2 '262026-06-307.3K
Q1 '262026-03-3132.7K
Q4 '252025-12-316K
Q4 '222022-12-3145K
Q3 '222022-09-3067.5K
Q2 '222022-06-3067.5K
Q1 '222022-03-3167.5K
Q4 '212021-12-31424.6K
Q3 '212021-09-30200K
Q4 '192019-12-310
Q3 '192019-09-300
Q2 '192019-06-300
Q1 '192019-03-313.3K
Q4 '172017-12-310
Q3 '172017-09-300
Q2 '172017-06-300
Q1 '172017-03-31500
Q4 '152015-12-310
Q3 '152015-09-300
Q2 '152015-06-3019.5K

Gross Profit Quarterly

PeriodEndingGross Profit
Q2 '152015-06-30-10.5K

Operating Income Quarterly

PeriodEndingOperating Income
Q2 '262026-06-30-500.6K
Q1 '262026-03-31-488.1K
Q4 '252025-12-31-12.7M
Q3 '252025-09-30-211.1K
Q2 '252025-06-30-79.3K
Q1 '252025-03-31-78.8K
Q4 '242024-12-31-64K
Q3 '242024-09-30-83.7K
Q2 '242024-06-30-57.9K
Q1 '242024-03-31-65.7K
Q4 '232023-12-31-4.4K
Q3 '232023-09-30-34.5K
Q2 '232023-06-30-41.2K
Q1 '232023-03-31-36.3K
Q4 '222022-12-31-19.9K
Q3 '222022-09-3042.6K
Q2 '222022-06-30-11.5K
Q1 '222022-03-31-34K
Q4 '212021-12-31315.2K
Q3 '212021-09-30100.2K

Net Income Quarterly

PeriodEndingNet Income
Q2 '262026-06-30-236.8K
Q1 '262026-03-31177.8K
Q4 '252025-12-31-28M
Q3 '252025-09-30-3.6M
Q2 '252025-06-30-146.1K
Q1 '252025-03-31-6.4K
Q4 '242024-12-31-117.7K
Q3 '242024-09-30-192.8K
Q2 '242024-06-30-100.7K
Q1 '242024-03-31-116.9K
Q4 '232023-12-31-128.8K
Q3 '232023-09-30-68.7K
Q2 '232023-06-30-96.8K
Q1 '232023-03-31-87.3K
Q4 '222022-12-31-196.4K
Q3 '222022-09-30-142.6K
Q2 '222022-06-30-207.4K
Q1 '222022-03-31-222K
Q3 '212021-09-303.1M
Q2 '212021-06-30-182.5K

Cost of Revenue Quarterly

PeriodEndingCost of Revenue
Q2 '152015-06-3030K

Operating Cash Flow Quarterly

PeriodEndingOperating Cash Flow
Q2 '262026-06-30-98.9K
Q1 '262026-03-31-142.6K
Q4 '252025-12-31-163.5K
Q3 '252025-09-30-35.9K
Q2 '252025-06-30-34.9K
Q1 '252025-03-31-22.7K
Q4 '242024-12-31-44.7K
Q3 '242024-09-30-43.4K
Q2 '242024-06-30-69K
Q1 '242024-03-31-37K
Q4 '232023-12-31-32.8K
Q3 '232023-09-30-36.8K
Q2 '232023-06-30-38.7K
Q1 '232023-03-31-14.2K
Q4 '222022-12-31-34.4K
Q3 '222022-09-3042K
Q2 '222022-06-3013.9K
Q1 '222022-03-31-13.7K
Q4 '212021-12-315K
Q3 '212021-09-30123.2K

Free Cash Flow Quarterly

Operating cash flow minus capital expenditure.

PeriodEndingFree Cash Flow
Q4 '212021-12-315K
Q3 '212021-09-30123.2K
Q2 '182018-06-30-112.5K
Q1 '182018-03-31-117.7K
Q4 '162016-12-31-160.8K
Q3 '162016-09-30-149.1K

Shares Outstanding Quarterly

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

PeriodEndingShares Outstanding
Q2 '262026-06-3046.9M
Q1 '262026-03-3146.9M
Q3 '252025-09-3022M
Q2 '252025-06-3021.7M
Q1 '252025-03-3126M
Q3 '242024-09-3021.7M
Q2 '242024-06-3021.7M
Q1 '242024-03-3121.7M
Q3 '232023-09-3021.7M
Q2 '232023-06-3021.7M
Q1 '232023-03-3121.7M
Q3 '222022-09-3021.7M
Q2 '222022-06-3021.7M
Q1 '222022-03-3121.7M
Q3 '212021-09-3025M
Q2 '212021-06-3021.7M
Q1 '212021-03-3121.7M
Q3 '202020-09-3021.7M
Q1 '192019-03-3121.6M
Q1 '182018-03-3124.6M

EPS TTM

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

PeriodEndingEPS
Q2 '262026-06-30-1.23
Q1 '262026-03-31-1.23
Q4 '252025-12-31-1.23
Q3 '252025-09-30-0.17
Q2 '252025-06-30-0.02
Q1 '252025-03-31-0.01
Q4 '242024-12-31-0.01
Q3 '242024-09-30-0.02
Q2 '242024-06-30-0.01
Q1 '242024-03-31-0.01
Q4 '232023-12-31-0.01
Q3 '232023-09-300.06
Q2 '232023-06-300.06
Q1 '232023-03-310.05
Q4 '222022-12-310.04
Q3 '212021-09-300.15
Q2 '212021-06-300.01
Q1 '212021-03-310.02
Q4 '202020-12-310.02
Q3 '202020-09-30-0.03